The Feasibility of Dexmedetomidine for Awake Fiberoptic Nasal Intubation
Status:
Unknown status
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the feasibility of dexmedetomidine infusion for
oral cancer patients undergoing awake fiberoptic nasal intubation. We hypothesized that a
loading dose of intravenous dexmedetomidine before awake fiberoptic nasal intubation for oral
cancer patients undergoing general anesthesia will provide adequate sedation and analgesia
without respiratory depression and upper airway obstruction.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital